# Gilead Sciences

Type: Company

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/gilead-sciences
Canonical HTML page: https://getlegalbrief.com/entity/gilead-sciences

## Timeline

- **2026-07-01**: Regulatory Implementation — Effective date for the first wave of state-level ADAP regulatory changes and income threshold adjustments.
- **2026-03-17**: State Announcements — Multiple states officially announce new eligibility restrictions and the implementation of waitlist protocols.
- **2026-01-20**: Federal Guidance — HRSA issues guidance on state flexibility for utilizing Ryan White Part B funds amid rising drug costs.
- **2025-11-15**: Budget Proposals — Initial state budget drafts suggest significant shortfalls in ADAP funding for the 2026 fiscal year.

## Recent coverage (1 stories)

### State Regulatory Shifts Tighten HIV Drug Assistance Program Eligibility
2026-03-17 21:14:53 · Sentiment: Negative · Impact: 6/10 · Sources: 2

Multiple states have begun implementing restrictive eligibility requirements for HIV Drug Assistance Programs (ADAPs) due to budgetary constraints. These regulatory changes are expected to increase compliance burdens for healthcare providers and reshape pharmaceutical procurement strategies.
Full story: https://getlegalbrief.com/story/state-hiv-drug-assistance-limits-regulation

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.